According to a new study conducted by the Moffitt Cancer Center in the U.S., green tea intake lead to a reduced risk of prostate cancer.
The beneficial properties of green tea have long been debated in alleviating a wide array of problems of the human body. From a trusty partner in weight-loss efforts to kidney medical problems, green tea is recommended by medical specialists worldwide.
This new study comes to add to the vetted benefits of the herbal drink. Green tea intake prevents prostate cancer due to compounds found in the leaves, catechins.
Asia accounts for twenty percent of the world’s green tea intake. Here, as well, prostate cancer percentage are the lowest on the globe. Due to migration, it seems that dietary habits change, and the health condition of Asian men also registers changes.
That is why the team of Dr. Nagi Kumar, lead author of the study from the Moffitt Center decided to look into the effects of green tea on the male population. In the United States, prostate cancer ranks as the second most encountered type of cancer among the male segment of the population. This year alone, it is expected statistically that 220,000 new cases will be diagnosed.
Under these circumstance the results of the research team are important in reducing the number of diagnosed cases if guidelines are followed accurately. The catechins are a natural way of preventing the expansion of cancer cells. Catechins also attack the ability of cancer cells to invade other healthy cells.
Patients that participated in the research were split in two groups. One of the groups was administered Polyphenon E, in capsules. The second group was administered placebos. Both groups were monitored over a period of one year.
Researchers found that the first group that was administered Polyphenon E capsules presented a significant decrease for the prostate-specific antigen levels (PSA).
PSA is a biomarker that is being used by physicians when screening patients for prostate cancer. If the level of PSA is found to be high, physicians are warning patients of a higher risk to develop prostate cancer.
Image Source: www.humanithe.fr